Villaroya, Guillerma O.
HRN: 19-46-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/17/2022
12/19/2022
IV
600mg
Q6
Sepsis, DM Foot, Cellulitis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueUnspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes